19 results
8-K
EX-10.1
XLO
Xilio Therapeutics Inc
3 Jan 24
Departure of Directors or Certain Officers
4:05pm
.
9.Data Privacy Consent.
In order to administer the Plan and this agreement and to implement or structure future equity grants, the Company, its
10-K
ldlhrn
1 Mar 22
Annual report
4:07pm
10-Q
eej4etbg 7ot
2 Dec 21
Quarterly report
4:15pm
424B4
g1os nm86j5
22 Oct 21
Prospectus supplement with pricing info
4:02pm
S-1/A
zktt6 mqn4ha
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
EX-10.7
k2uuqfu1l5zk vl
18 Oct 21
IPO registration (amended)
6:04am
S-1/A
EX-10.6
fenboy2
18 Oct 21
IPO registration (amended)
6:04am
S-1
wv44fslheyn0648 wk
1 Oct 21
IPO registration
4:49pm
DRS/A
b85 wzikwf7offth12op
14 Sep 21
Draft registration statement (amended)
12:00am
DRS
twktx67ky77 xnr2s2
24 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next